Trademarkia Logo

Canada

C$
ABSTRACTED ANTIBODY DESIGN
CANCELLED

Last Applicant/ Owned by

CytoDyn Inc.

Suite 660, 1111 Main StreetVancouver WA 98660

US

Serial Number

2092630 filed on 1st Dec 2020

Registration Number

TMA1216939 registered on 5th Jan 2024

Registration expiry Date

1st Dec 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

ABSTRACTED ANTIBODY DESIGN

Trademark usage description

therapeutic preparations, namely, therapeutic preparations for the treatment of hiv, cancer, graft-versushost disease, autoimmune diseases, nonalcohol Read More

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 10

Circles or ellipses containing one or more triangles or lines forming an angleCercles ou ellipses contenant un ou plusieurs triangles ou des lignes formant un angle

26 . 1 . 12

Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

Classification Information


Class [005]
Therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versushost disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders, COVID- 19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor.


Classification kind code

11

Class [042]
Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor.


Classification kind code

11

Class [044]
Providing health and medical information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system diseases, respiratory diseases and disorders, COVID-19, via a website; providing information in the field of antibodies for use in targeting the C-C chemokine receptor type 5 cell receptor, via a website; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graftversus- host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19.


Classification kind code

11

Mark Details


Serial Number

2092630

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 14th Jul 2022
Search Recorded
Submitted for opposition 20
on 14th Jul 2022
Examiner's First Report
Submitted for opposition 223
on 14th Jul 2022
Total Provisional Refusal
Submitted for opposition 256
on 18th Jan 2022
Notification of Possible Opposition Sent
Submitted for opposition 48
on 22nd Nov 2021
Agent Changed
Submitted for opposition 257
on 18th Mar 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 17th Mar 2021
Formalized
Submitted for opposition 1
on 17th Mar 2021
Created
Submitted for opposition 228
on 1st Dec 2020
International Registration
Submitted for opposition 30
on 1st Dec 2020
Filed